U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07544628) titled 'A Phase 1 Study of Navlimetostat Tablet Formulations' on April 16.
Brief Summary: This study aims to compare the PK of Navlimetostat after administration of a wet-granulation tablet versus the dry-granulation tablet formulation in healthy adult female
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Navlimetostat
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital Content Services with permission from Health Daily Digest....